The neuroprotective potential of retinal Müller glial cells.
    
    
        
    
    
        
        Adv. Exp. Med. Biol. 801, 381-387 (2014)
    
    
 	
    
	
	  DOI
 DOI
	  PMC
 PMC
		
		
			Open Access Green as soon as Postprint is submitted to ZB.
		
     
    
      
      
	
	    Retinal Müller glial cells (RMG) are recognized as essential players providing neurotrophic, metabolic and structural support for retinal neurons as well as mediating inflammatory responses in the retina. While some key neuroprotective molecules in the context of retinal degeneration, such as FGF2, LIF, PEDF have been demonstrated to be of RMG origin, there is yet no comprehensive understanding on the multifaceted role of RMG in orchestrating diverse intercellular functions. In order to systematically as well as functionally analyse RMG reactivity to retinal degeneration and thus explore the RMG-derived signalling molecules in depth, we combined genomics and proteomics approaches based on profiling primary RMGs from mouse and pig. However, since modulations in cell to cell communication by secretion of molecules may not necessarily present with changes in the mRNA profile, we developed shotgun proteomics approaches enabling direct protein profiling of the RMG lysates and secretomes using label-free and SILAC quantitations. We have identified a pool of novel proteins relevant for pro-survival effects transmitted from RMG to retinal neurons and functionally valdidated selected molecules. Additionally, our approach allows to identify RMG reactions to intrinsic and extrinsic stimuli and thus enables to molecularly dissect RMG reactivity relevant for retinal health and disease.
	
	
	    
	
       
      
	
	    
		Impact Factor
		Scopus SNIP
		Web of Science
Times Cited
		Scopus
Cited By
		Altmetric
		
	     
	    
	 
       
      
     
    
        Publication type
        Article: Journal article
    
 
    
        Document type
        Scientific Article
    
 
    
        Thesis type
        
    
 
    
    
        Keywords
        Neuroprotection ; Mass spectrometry ; Quantitative proteomics ; Secretome; Endothelial Growth-factor; In-vitro; Expression; Proteomics; Proteins; Survival
    
 
    
        Keywords plus
        
    
 
    
    
        Language
        english
    
 
    
        Publication Year
        2014
    
 
    
        Prepublished in Year
        
    
 
    
        HGF-reported in Year
        2014
    
 
    
    
        ISSN (print) / ISBN
        0065-2598
    
 
    
        e-ISSN
        
    
 
    
        ISBN
        978-1-4614-3208-1
    
    
        Book Volume Title
        
    
 
    
        Conference Title
        Retinal Degenerative Diseases : Mechanisms and Experimental Therapy
    
 
	
        Conference Date
        
    
     
	
        Conference Location
        
    
 
	
        Proceedings Title
        
    
 
     
	
    
        Quellenangaben
        
	    Volume: 801,  
	    Issue: ,  
	    Pages: 381-387 
	    Article Number: ,  
	    Supplement: ,  
	
    
 
    
        
            Series
            
        
 
        
            Publisher
            Springer
        
 
        
            Publishing Place
            New York
        
 
	
        
            Day of Oral Examination
            0000-00-00
        
 
        
            Advisor
            
        
 
        
            Referee
            
        
 
        
            Examiner
            
        
 
        
            Topic
            
        
 
	
        
            University
            
        
 
        
            University place
            
        
 
        
            Faculty
            
        
 
    
        
            Publication date
            0000-00-00
        
 
         
        
            Application date
            0000-00-00
        
 
        
            Patent owner
            
        
 
        
            Further owners
            
        
 
        
            Application country
            
        
 
        
            Patent priority
            
        
 
    
        Reviewing status
        Peer reviewed
    
 
     
    
        POF-Topic(s)
        30203 - Molecular Targets and Therapies
    
 
    
        Research field(s)
        Enabling and Novel Technologies
    
 
    
        PSP Element(s)
        G-505700-001
    
 
    
        Grants
        
    
 
    
        Copyright
        
    
 	
    
    
    
    
    
        Erfassungsdatum
        2014-06-06